Stay updated with breaking news from Covishield Efficacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pune-based Serum Institute of India (SII) has applied for full market authorisation for COVID-19 vaccine Covishield with the drug regulator. SII CEO Adar Poonawala confirmed that the institute has applied for full market authorisation of Covishield, stating supplies of the COVID-19 vaccine have exce
The vaccine had an efficacy of 63 per cent in fully vaccinated people, while it was 81 per cent effective against moderate-to-severe disease.
The exact percentage of seropositivity rates between Covishield and Covaxin recipients will only be determined in a head-to-head trial, said the authors of the study.
India removes import duty on remdesivir until October Starting May 1, the central government has allowed anyone above the age of 18 to get vaccinated against COVID-19. To do so, the government recommended eligible citizens to use CoWin website for advance booking, which will commence from April 28. Another major change concerning vaccines that takes effect on May 1 is that state governments and private hospitals can independently procure vaccines and administer them at a fixed price per dose. India currently has two vaccines, Covaxin and Covishield, authorised for emergency use. Here's how th...
Covishield most affordable Covid-19 vaccine in the market: SII responds to concerns over pricing Only a limited portion of Covishield doses will be sold to private hospitals at Rs 600 per dose, the Serum Institute said in response to skepticism over the prices of its Covid-19 vaccine. advertisement File photo of Serum Institute of India facility in Pune (Photo Credits: PTI) HIGHLIGHTS SII fixed the price of Covishield at Rs 600/dose for private hospitals and Rs 400 for state govts Initial supply of Covishield for immunization programme in India has been the lowest: Serum Institute Earlier, SI...